• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nasopharyngeal metastasis of breast carcinoma with HER 2 discordance: a case report.

作者信息

Copson Bridget, Pratap Upasna, McLean Catriona, Hayes Theresa

机构信息

Department of Otolaryngology, Alfred Health, Melbourne, Victoria, Australia.

Department of Anatomical Pathology, Alfred Health, Melbourne, Victoria, Australia.

出版信息

ANZ J Surg. 2018 May;88(5):508-509. doi: 10.1111/ans.13446. Epub 2016 Feb 22.

DOI:10.1111/ans.13446
PMID:26909745
Abstract
摘要

相似文献

1
Nasopharyngeal metastasis of breast carcinoma with HER 2 discordance: a case report.HER2不一致性乳腺癌的鼻咽转移：一例报告
ANZ J Surg. 2018 May;88(5):508-509. doi: 10.1111/ans.13446. Epub 2016 Feb 22.
2
How we treat locally advanced HER2-positive breast cancer.
Clin Adv Hematol Oncol. 2019 May;17(5):271-280.
3
Analysis of HER Family (HER1-4) Expression as a Biomarker in Combination Therapy with Pertuzumab, Trastuzumab and Docetaxel for Advanced HER2-positive Breast Cancer.分析HER家族（HER1-4）表达作为帕妥珠单抗、曲妥珠单抗和多西他赛联合治疗晚期HER2阳性乳腺癌的生物标志物
Anticancer Res. 2018 Apr;38(4):2285-2294. doi: 10.21873/anticanres.12473.
4
[HER2-positive breast cancer: standard and double targeted therapy].[人表皮生长因子受体2阳性乳腺癌：标准治疗与双重靶向治疗]
Vopr Onkol. 2013;59(3):341-6.
5
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.新辅助帕妥珠单抗和曲妥珠单抗治疗局部晚期、炎症型或早期 HER2 阳性乳腺癌的疗效和安全性（NeoSphere）：一项随机、多中心、开放性、Ⅱ期临床试验。
Lancet Oncol. 2012 Jan;13(1):25-32. doi: 10.1016/S1470-2045(11)70336-9. Epub 2011 Dec 6.
6
Duration of trastuzumab for HER2-positive breast cancer.曲妥珠单抗用于HER2阳性乳腺癌的疗程
Lancet Oncol. 2013 Jul;14(8):678-9. doi: 10.1016/S1470-2045(13)70273-0. Epub 2013 Jun 11.
7
[A Case of Luminal-HER2 Advanced Breast Cancer with Liver Metastasis Showed Pathological Complete Response to the Therapy with Pertuzumab plus Trastuzumab plus Docetaxel].[1例伴有肝转移的管腔型HER2阳性晚期乳腺癌对帕妥珠单抗联合曲妥珠单抗加多西他赛治疗显示出病理完全缓解]
Gan To Kagaku Ryoho. 2016 Sep;43(9):1097-100.
8
[A Case of HER2-Positive Breast Cancer with Newly Diagnosed Stage IV That Responded to First-Line Pertuzumab and Trastuzumab-Based Therapy].
Gan To Kagaku Ryoho. 2017 Nov;44(12):1214-1216.
9
[Current possibilities of targeted therapy in the treatment of breast cancer with overexpression of HER-2/neu and metastatic lesions in the brain].
Vopr Onkol. 2013;59(3):347-51.
10
Metastatic breast cancer treated with lapatinib with a prolonged benefit: a case report and a review of therapeutic options available.拉帕替尼治疗转移性乳腺癌获长期获益：一例病例报告及现有治疗选择综述
Tumori. 2013 Nov-Dec;99(6):269e-72e. doi: 10.1700/1390.15466.

引用本文的文献

1
Breast cancer metastasis to the nasopharynx: A case report.乳腺癌转移至鼻咽部：一例报告。
Oncol Lett. 2025 May 7;30(1):331. doi: 10.3892/ol.2025.15077. eCollection 2025 Jul.
2
Rare sites of breast cancer metastasis: a review.乳腺癌转移的罕见部位：综述
Transl Cancer Res. 2019 Oct;8(Suppl 5):S518-S552. doi: 10.21037/tcr.2019.07.24.
3
Metastatic pulmonary adenocarcinoma to the nasopharynx at first clinical presentation: A case report and review of literature.首例临床表现为鼻咽癌转移的肺腺癌：病例报告及文献复习
SAGE Open Med Case Rep. 2020 Jul 15;8:2050313X20939826. doi: 10.1177/2050313X20939826. eCollection 2020.